Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Burger

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.
Molecular Cancer Therapeutics|December 4, 2025
Inhibition of CDKs Enhances Efficacy of Anti-EGFR Therapy in ChordomaTianna Zhao, Riccardo Serra, Michelle Guo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2016
Next-generation sequencing in neuropathologic diagnosis of infections of the nervous systemSteven L Salzberg, Florian P Breitwieser, Anupama Kumar, et al.
Swiss Medical Weekly|October 20, 2021
The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccinationPhilip Haaf, Gabriela M Kuster, Christian Mueller, et al.
Annals of Neurology|November 30, 2005
Progressive cavitating leukoencephalopathy: a novel childhood diseaseSakkuBai Naidu, Genila Bibat, Doris Lin, et al.
Blood|May 19, 2007
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesisYu-Tzu Tai, Mariateresa Fulciniti, Teru Hideshima, et al.
Scientific Reports|December 12, 2019
Genomic Landscape of Intramedullary Spinal Cord GliomasMing Zhang, Rajiv R Iyer, Tej D Azad, et al.
Journal of Neuro-Oncology|November 30, 2005
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology groupMurali M Chintagumpala, Henry S Friedman, Clinton F Stewart, et al.
British Journal of Haematology|March 25, 2010
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivoKihyun Kim, Sun-Young Kong, Mariateresa Fulciniti, et al.
Blood|February 7, 2009
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cellsYu-Tzu Tai, Ender Soydan, Weihua Song, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.
Molecular Cancer Therapeutics|December 4, 2025
Inhibition of CDKs Enhances Efficacy of Anti-EGFR Therapy in ChordomaTianna Zhao, Riccardo Serra, Michelle Guo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2016
Next-generation sequencing in neuropathologic diagnosis of infections of the nervous systemSteven L Salzberg, Florian P Breitwieser, Anupama Kumar, et al.
Swiss Medical Weekly|October 20, 2021
The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccinationPhilip Haaf, Gabriela M Kuster, Christian Mueller, et al.
Annals of Neurology|November 30, 2005
Progressive cavitating leukoencephalopathy: a novel childhood diseaseSakkuBai Naidu, Genila Bibat, Doris Lin, et al.
Blood|May 19, 2007
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesisYu-Tzu Tai, Mariateresa Fulciniti, Teru Hideshima, et al.
Scientific Reports|December 12, 2019
Genomic Landscape of Intramedullary Spinal Cord GliomasMing Zhang, Rajiv R Iyer, Tej D Azad, et al.
Journal of Neuro-Oncology|November 30, 2005
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology groupMurali M Chintagumpala, Henry S Friedman, Clinton F Stewart, et al.
British Journal of Haematology|March 25, 2010
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivoKihyun Kim, Sun-Young Kong, Mariateresa Fulciniti, et al.
Blood|February 7, 2009
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cellsYu-Tzu Tai, Ender Soydan, Weihua Song, et al.
Pageof 7